当前所在位置: 首页 > 今日热点 2020-10-17 12:40:42 来源:网络来源 点击数: 本文分类:今日热点


Bayer周二宣布,总部位于美国的公司Elanco Animal Health已签订收购拜耳动物保健业务的最终协议。  根据2019年8月6日的未受影响的30天成交量加权平均价格,该交易价值76亿美元,包括53亿美元现金,根

Bayer周二宣布,总部位于美国的公司Elanco Animal Health已签订收购拜耳动物保健业务的最终协议。


  “这项交易增强了我们作为生命科学领域全球领导者的重点,”拜耳公司管理委员会主席Werner Baumann说。动物健康业务的退出标志着拜耳于2018年11月发起的一系列投资组合措施中的最大交易。该公司此前已宣布剥离其消费者健康品牌Coppertone™和Dr.Scholl's™以及其60美元的销售德国网站服务提供商Currenta的最高股份。“因此,我们提前完成了我们在2018年12月资本市场日传达的推动价值创造的关键优先事项之一”,Baumann说。


  “我非常尊重拜耳动物保健团队以及他们对改善动物健康和福祉的共同热情,”Elanco总裁兼首席执行官Jeffrey N.Simmons说。“结合Elanco与兽医的密切关系以及拜耳在零售和电子商务领域的领导地位将最终使我们的所有客户受益。我们期待加入我们的配套组合和能力,建立一个完全专注的动物保健公司,为农民,兽医和宠物主人提供持续的创新流程。“




  英文版:Bayer to sell its Animal Health business unit to Elanco

  U.S.-based company Elanco Animal Health has entered into a definitive agreement to acquire Bayer’s Animal Health business,Bayer announced on Tuesday.

  The transaction is valued at 7.6 billion U.S.dollars consisting of 5.3 billion U.S.dollars in cash,subject to customary purchase price adjustments,and 2.3 billion U.S.dollars in Elanco stock based on the unaffected 30-day volume weighted average price as of August 6,2019.The value of the equity consideration is fixed within a 7.5 percent collar.The transaction value represents an implied multiple of 18.8x based on the 12 months EBITDA before special items of Bayer Animal Health as of June 30,2019.The divestment is expected to be concluded in mid-2020 subject to the satisfaction of customary closing conditions,including antitrust clearance.Bayer intends to exit its stake in Elanco over time.

  “This transaction enhances our focus as a global leader in life sciences,”said Werner Baumann,Chairman of the Board of Management of Bayer AG.The exit of the Animal Health business marks the largest transaction in the series of portfolio measures initiated by Bayer in November 2018.The company had previously announced the divestiture of its Consumer Health brands Coppertone™and Dr.Scholl’s™along with the sale of its 60-percent stake in German site services provider Currenta.“We are therefore delivering ahead of schedule on one of the key priorities for driving value creation that we communicated at our Capital Markets Day in December 2018”,said Baumann.

  The combination is highly complementary and creates the number two animal health company,with top three positions across a broad range of species and geographies.It also enhances Elanco’s portfolio of leading global brands and bolsters its innovation capabilities and R&D pipeline.

  “I have tremendous respect for the Bayer Animal Health team and their shared passion for improving the health and well-being of animals,”said Jeffrey N.Simmons,president and chief executive officer of Elanco.“Combining Elanco’s strong relationship with veterinarians and Bayer’s leadership in retail and e-commerce will ultimately benefit all our customers.We look forward to joining our complementary portfolios and capabilities to build a fully focused animal health company,providing a sustained flow of innovation for farmers,veterinarians and pet owners.”

  Bayer’s Animal Health business is a global leader in the segment with sales of 1.8 billion U.S.dollars in fiscal 2018.It develops and markets innovative products and solutions to prevent and treat diseases in companion and farm animals.The Advantage™family of flea,tick and worm control products,for instance,has been among the most successful products on the market for years.In addition,the innovative Seresto™collar is one of the fastest-growing products in this area.

  “We would like to thank all our Animal Health employees for the commitment they have shown over the years and for the success this has brought to Bayer and to our Animal Health business.We were also able to safeguard the interests of our employees,”said Baumann.Under the agreement with Elanco,all Bayer Animal Health employees will have at least one year of employment protection against unilateral termination with similar and no less favorable benefits in the aggregate.

  Bank of America Merrill Lynch and Credit Suisse acted as financial advisors to Bayer,while Sullivan&Cromwell,PwC Legal and Linklaters acted as legal advisors.


  • 英雄联盟更新慢怎么办 英雄联盟更新被限速怎么办 LOL破解限速教程 英雄联盟更新慢怎么办 英雄联盟更新被限速怎么办 LOL破解限速教程
  • 中兰高铁 中兰铁路靖远段开工,建成后7小时左右到北京,途经这些地方…… 中兰高铁 中兰铁路靖远段开工,建成后7小时左右到北京,途经这些地方……
  • 安妮情人节皮肤 LOL9月活动有哪些 安妮的小卖部开张主打情人节限定皮肤 安妮情人节皮肤 LOL9月活动有哪些 安妮的小卖部开张主打情人节限定皮肤
  • 宝骏rs5报价及图片 宝骏rS5报价及参数 宝骏rs5报价及图片 宝骏rS5报价及参数
  • 川航空姐 川航空姐跳楼 该空姐是谁被网友们猜测 川航空姐 川航空姐跳楼 该空姐是谁被网友们猜测
  • 朱锐 中科微光总裁朱锐:创业之星做出最牛内窥镜 朱锐 中科微光总裁朱锐:创业之星做出最牛内窥镜
  • 穆棱一中 18款宝马X5港口特价 老款库存现车报价 穆棱一中 18款宝马X5港口特价 老款库存现车报价
  • 脚底起皮是什么原因 脚脱皮是什么原因?脚为什么会随便脱皮 脚底起皮是什么原因 脚脱皮是什么原因?脚为什么会随便脱皮